I-Bendroflumethiazide Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

i-bendroflumethiazide

ipca pharma (nz) pty limited - bendroflumethiazide 5mg;  ;   - tablet - 5 mg - active: bendroflumethiazide 5mg     excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Bendroflumethiazide Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

bendroflumethiazide

ipca pharma (nz) pty limited - bendroflumethiazide 2.5mg;  ;   - tablet - 2.5 mg - active: bendroflumethiazide 2.5mg     excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Bendroflumethiazide Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

bendroflumethiazide

ipca pharma (nz) pty limited - bendroflumethiazide 5mg;  ;   - tablet - 5 mg - active: bendroflumethiazide 5mg     excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Bendroflumethiazide 2.5mg Tablets Мальта - английский - Medicines Authority

bendroflumethiazide 2.5mg tablets

p & d pharmaceuticals limited - bendroflumethiazide 2.5 mg - tablet

Bendroflumethiazide Tablets 2.5mg Мальта - английский - Medicines Authority

bendroflumethiazide tablets 2.5mg

bristol laboratories limited - bendroflumethiazide 2.5 mg - tablet